A Pilot Phase II Trial of Cabergoline in the Treatment of Metastatic Breast Cancer
Phase of Trial: Phase 0
Latest Information Update: 18 Sep 2019
Price : $35 *
At a glance
- Drugs Cabergoline (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 22 Mar 2019 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 02 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.